Navigation Links
Pharmasset to Webcast an Investor Event from the AASLD Meeting
Date:11/1/2009

ur collaboration with Roche will not continue or will not be successful and the risk that any one or more of our product candidates will not be successfully developed and commercialized. For a discussion of these risks and uncertainties, any of which could cause our actual results to differ from those contained in the forward-looking statements, see the section of our Annual Report on Form 10-K for the fiscal year ended September 30, 2008 and our Quarterly Report on Form 10-Q for the period ended June 30, 2009 filed with the Securities and Exchange Commission entitled "Risk Factors" and discussions of potential risks and uncertainties in our subsequent filings with the Securities and Exchange Commission.

www.pharmasset.com

    Contact
    Richard E. T. Smith, Ph.D.
    VP, Investor Relations and Corporate Communications
    richard.smith@pharmasset.com
    Office: +1 (609) 613-4181

SOURCE Pharmasset, Inc.


'/>"/>
SOURCE Pharmasset, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Pharmasset and Roche to Present R7128 Data at the 14th International Symposium on Hepatitis C Virus and Related Viruses
2. Pharmasset to Present at the UBS Global Life Sciences Conference on Monday, September 24th
3. Pharmasset Accesses up to $30 Million of Working Capital
4. Pharmasset to Present at Three Investor Conferences in November 2007
5. Pharmasset Appoints Michael Rogers as Chief Development Officer
6. Pharmasset Reports Fiscal Year End 2007 Financial Results
7. Pharmasset to Present at the BIO CEO & Investor Conference 2008 on Monday, February 11th
8. Pharmasset to Present at Susquehannas Second Annual SIGnificant Investment Options in Healthcare Conference on Wednesday, March 5th
9. Pharmasset to Present at Cowen & Companys Health Care Conference on Tuesday, March 18th
10. Pharmasset Appoints Herbert J. Conrad as a Director
11. Pharmasset Receives $10 Million of Working Capital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... Cleveland-based Life Line Screening allows users to easily find and ... to expect at a health screening, share comments, view personal ... YouTube. The health screening company’s new site ... ... Cleveland, OH (PRWEB) December 17, 2009 -- ...
(Date:12/16/2009)... among historians, journalists and politicians, and has been recounted ... U.S. Congress: British forces used chemical weapons on Iraqis ... claim has never been fully squared with the historical ... University. According to Douglas,s research, forthcoming in the December ... no such incident ever occurred. , Allegations of ...
(Date:12/16/2009)... from roadside bombs to freeway crashes. Traumatic injury, the ... 44, often overwhelms the body,s natural blood-clotting process. , ... team led by Erin Lavik, a new Case Western ... student, James P. Bertram, built synthetic platelets that show ... is published in Science Translational Medicine ., The ...
(Date:12/16/2009)... Hahnemann among the Best in the Nation ... Hospital proudly announces it has been granted Magnet(R) ... Magnet Recognition Program(R). Magnet(R) is one of the ... center can achieve, and places Hahnemann among the ... have achieved this prestigious distinction. ,, At 9:00 ...
Breaking Biology Technology:Website Redesign Enhances Global Health Screening Service's Online Presence 2Website Redesign Enhances Global Health Screening Service's Online Presence 3Despite claims, UK did not gas Iraqis in the 1920s, new research finds 2Despite claims, UK did not gas Iraqis in the 1920s, new research finds 3Despite claims, UK did not gas Iraqis in the 1920s, new research finds 4Researchers take the inside route to halt bleeding 2Hahnemann University Hospital Granted Magnet(R) Status 2Hahnemann University Hospital Granted Magnet(R) Status 3
... wireless keeps growing at its present rate employees may not ... a wireless channel manager for Cisco Systems. , ... Madison program, saying the surging interest in wireless communications ... few years. With costs falling and enhancements increasing, mobility has ...
... Wis. -- A proposed ban on all human embryonic ... state Senate Tuesday, a proposal opposed by many in the ... 499, would outlaw not only cloning for reproductive purposes but ... an embryo is created with identical DNA as an original ...
... West Allis, Wis. -- A Web-based system known ... EMSystem of West Allis is being used ... the multi-state region that continues to be affected by ... of Hurricane Katrina, the U.S. Department of Health and ...
Other Biology Technology:Cisco manager touts wireless advantages 2Cloning ban comes before Wisconsin Senate on Tuesday 2Cloning ban comes before Wisconsin Senate on Tuesday 3Healthcare needs of hurricane-hit region being monitored by West Allis company's system 2
(Date:12/16/2009)... Biologists determined that short-term, seasonal exposure to pesticides ... and size of wild salmon populations. In addition ... findings suggest that exposure to commonly used pesticides ... endangered populations. , "Major efforts are currently ... effort to recover depressed populations," says David Baldwin ...
(Date:12/16/2009)... global provider of business process outsourcing (BPO) services, was ... Top 100 IT project of 2009 for its biometric-enabled ... iQor. ,, "We are honored to be recognized among ... and CEO of iQor. "TeQ21 is completely transforming the ... smarter and with the added security biometrics provides. We ...
(Date:12/16/2009)... BIO-key International, Inc. (OTC Bulletin ... safety and finger-based biometric identification solutions, announced ... a Special Shareholder Meeting held today approved ... Division to Interact911 Mobile Systems Inc. Of ... favor and 1.2% were opposed. ,, (Logo: ...
Breaking Biology News(10 mins):Even at sublethal levels, pesticides may slow the recovery of wild salmon populations 2iQor Named to InfoWorld 100 List of Top IT Projects of 2009 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3Webcast Alert 3A HCA Healthcare Announces HCA 2Q09 Earnings Report 53418 1Terrosa Technologies Assigned as Exclusive Reseller for Inclinicalperform CTMS SaaS Clinical Trials Collaboration Software 13315 1Terrosa Technologies Assigned as Exclusive Reseller for Inclinicalperform CTMS SaaS Clinical Trials Collaboration Software 13315 2Terrosa Technologies Assigned as Exclusive Reseller for Inclinicalperform CTMS SaaS Clinical Trials Collaboration Software 13315 3Webinar on 26quot 3BPhysician Engagement Diagnosing Generational Differences 26quot 3B Presented by Morehead Associates 53414 1Webinar on 26quot 3BPhysician Engagement Diagnosing Generational Differences 26quot 3B Presented by Morehead Associates 53414 2Webinar on 26quot 3BPhysician Engagement Diagnosing Generational Differences 26quot 3B Presented by Morehead Associates 53414 3
... CAMBRIDGE, Mass. (March 26, 2009) The Howard Hughes ... an Early Career Scientist appointment, a six-year funded position ... , "I am thrilled to receive the HHMI Early ... remarkable history of supporting innovative and creative science, and ...
... MARCH 2009 More than 120 researchers will speak ... life sciences conference to be organized by the European ... 29 August to 1 September 2009. , The ... programmes reflecting the concepts and high-resolution approaches of modern ...
... is available in Spanish . , ... of psychosis and schizophrenia, and those episodes of psychosis ... characteristics, both before their appearance and in the clinical ... conclusions of the doctoral thesis "Neurodevelopment and environmental stress ...
Other Biology News:Whitehead member Peter Reddien named HHMI Early Career Scientist 2Call for abstracts and registration for the EMBO Meeting 2009 2Daily consumption of cannabis predisposes to the appearance of psychosis and schizophrenia 2
Request Info...
Anti-20S proteasome subunits alpha 1, 2, 3, 5, 6 & 7, clone MCP231 Immunogen: Dinitrophenylated proteasomes Molecular Weight: 29 and 32 kDa....
Mouse monoclonal [J53] to Thyroid Hormone Receptor beta 1 ( Abpromise for all tested applications). entrezGeneID: 7068 SwissProtID: P10828...
Anti-ADP-Ribosylation Factor 1, clone 3F1 Immunogen: Synthetic peptide corresponding to the C-terminal amino acid sequence of human ARF1. Available Date: 38495...
Biology Products: